Sigurdur Oli Olafsson is an Icelandic businessperson who has been at the helm of 5 different companies. Presently, he holds the position of Chief Executive Officer & Director at Hikma Pharmaceuticals Plc.
He is also on the board of The American-Scandinavian Foundation.
In the past he occupied the position of Chairman for Elucida Oncology, Inc., Principal at Pfizer Inc. and Principal at Pfizer Ltd. (a subsidiary of Pfizer Inc.), Chief Executive Officer of Actavis Group hf, Chief Executive Officer at Actavis, Inc., President of Actavis Pharma, Inc., Head-Drug Development at Omega Farma ehf, Global Vice President-Investor Relations at Actavis, Inc., Director at Allergan Plc and President & CEO-Global Generic Medicines at Teva Pharmaceuticals Ltd.
Sigurdur Oli Olafsson received a graduate degree from the University of Iceland.